Skip to main content

Table 1 Demographics

From: Antithrombotic drug removal with hemoadsorption during off-pump coronary artery bypass grafting

Variable

OPCAB + HA (n = 10)

Age, years

67.4 ± 9.2

Gender, male

8 (80)

Prior PCI

5 (50)

Emergency indication (< 24 h)

1 (10)

Urgent indication

9 (90)

Acetylsalicylic acid

10 (100)

Ticagrelor

8 (80)

Rivaroxaban

1 (10)

Ticagrelor + rivaroxaban

1 (10)

NYHA functional class III/IV

10 (100)

Hypertension

9 (90)

Diabetes (NIDDM/IDDM)

4/1 (34.2)

Hyperlipidaemia

10 (100)

History of smoking

6 (60)

Renal dysfunction (creatinine ≥ 1.3 mg/dL / failure (dialysis)

2 (80)

Ejection fraction normal

8 (20)

Ejection fraction moderate impaired (40%; 45%)

2 (20)

BMI

28,8 ± 4,3

BMI > 30

3 (30)

EuroSCORE II, %

2.9 ± 1.5

  1. Data are presented as number (%) or mean±SD; h, hours; OPCAB, off-pump coronary artery bypass grafting; HA, hemoadsorption; NYHA, New York Heart Association; EuroSCORE, European System for Cardiac Operative Risk Evaluation; NIDDM, non-insulin dependent diabetes mellitus; IDDM, insulin dependent diabetes mellitus; PCI, percutaneous coronary intervention; BMI, body mass index